Modulation of the maturing gut barrier and microbiota: A novel target in allergic disease

Current Pharmaceutical Design

Volumn 14, Issue 14, 2008, Pages 1368-1375

  Isolauri, Erika ^a   Kalliomaki M ^a   Laitinen, K ^a   Salminen, S ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Allergy; Atopic disease; Infant; Inflammation; Microbiota; Probiotics

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LACTOBACILLUS EXTRACT; LACTOBACILLUS FERMENTUM EXTRACT; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; OMEGA 3 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; PROTEIN DERIVATIVE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; RETINOL; STAT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR ELK 1; VANCOMYCIN;

ALLERGIC DISEASE; ANTIBIOTIC RESISTANCE; ARTIFICIAL MILK; ATOPIC DERMATITIS; ATOPY; BIFIDOBACTERIUM; BREAST FEEDING; CHILD CARE; CLINICAL TRIAL; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ECZEMA; FOOD COMPOSITION; GROWTH RETARDATION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; MACROPHAGE ACTIVATION; MICROBIAL ACTIVITY; MICROBIAL COLONIZATION; NONHUMAN; NUTRIENT SUPPLY; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; STOMACH FUNCTION;

DIET; FOOD HYPERSENSITIVITY; HUMANS; INFANT; INFANT FOOD; INFANT, NEWBORN; INTESTINAL MUCOSA; INTESTINES; PROBIOTICS;

EID: 47249106481     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784480207     Document Type: Review

References (84)

1. Cummings JH, Antoine JM, Aspiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder P, et al. PASSCLAIM (process for the Assessment of Scientific Support for Claims on Foods)- Gut health and immunity. Eur J Nutr 2004; 43 Suppl2: 118-73.
2. Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: Possible role in clinical disorders (an update). Gastroenterology 1993; 104: 622-39.
3. Rook GAW, Brunet LR. Microbes, immunoregulation, and the gut. Gut 2005; 54: 317-20.
4. Rautava S, Kalliomäki M, Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics. J Allergy Clin Inummol 2005; 116: 31-7.
5. Köhler H, McCormick BA, Walker WA. Bacterial-enterocyte cross-talk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003; 36: 175-85.
6. Kalliomäki MA, Walker WA. Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium. Gastroenterol Clin N Am 2005; 34: 383-99.
7. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303: 1662-5.
8. Shroff KE, Meslin K, Cebra JJ. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun 1995; 63: 3904-13.
9. Grönlund MM, Arvilommi H, Kero P, Lehtonen OP, Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: A prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child 2000; 83: F186-92.
10. Favier CF, Vaughan EE, de Vos WM, Akkermans ADL. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002; 68: 219-26.
11. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning? Gut 2002: 51: 51-5.
12. Martin R, Langa, S, Reviriego C, Jiminez E, Marin ML, Xaus J, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003; 143: 754-8.
13. Martin R, Langa S, Jimenez E, Marin M, Olivares M, Jimenez J, et al. The commensal microflora of human milk: New perspectives for food bacteriotherapy and probiotics. Trends Food Sci Tech 2004; 15: 121-27
14. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984; 28: 975-86.
15. Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, Wagendorp AC, Klein N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol. Nutr 2000; 30: 61-7.
16. Mackie RI, Sghir A, Gaskins, HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69: 1035S-45S.
17. Sakata S, Tonooka T, Ishizeki S, Takada M, Sakamoto M, Fukuyama M, et al. Culture-independent analysis of fecal microbiota in infants with special reference to Bifidobacterium species. FEMS Microbiol Lett 2005; 243: 417-23.
18. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in inflants developing or not developing atopy. J Allergy and Clin Immunol. 2001: 107: 129-34.
19. Benno Y, He F, Hosoda M, Hashimoto H, Kojima T, Yamazaki K, et al. Effects of Lactobacillus GG yogurt an human intestinal microecology in Japanese subjects. Nutr Today 1996; 31: 9-11.
20. Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. Microbiota composition of the intestinal mucosa: Association with fecal microbiota? Microbiol Immunol 2004; 48: 497-500.
21. Cario E. Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 2005; 54: 1182-1193.
22. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-74.
23. van Heel DA, Ghosh S, Hunt KA, Mathew CG, Forbes A, Jewell DP, et al. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 2005; 54: 1553-7.
24. MacDonald TT, Gordon JN. Bacterial regulation of intestinal immune responses. Gastroenterol Clin N Am 2005; 34: 401-12.
25. Ormala T, Rintala R, Savilahti E. T-Cells and HLA-class II expression in the large intestine of infants in the early postnatal period. J Pediatr Gastroenterol Nutr 1998; 26; 422-8.
26. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-41.
27. Mazmanian SK, Liu CH, Tzianaboa AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-18.
28. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenetrol Clin North Am 2005; 34: 437-50.
29. de Vos WM, Bron PA, Kleerebezem M. Post-genomics of lactic acid bacteria and other food-grade bacteria to discover gut functionality. Curr Opin Biotechnol 2004; 15: 86-93.
30. Di Caro S, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR, et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 2005; 37: 320-9.
31. Callanan M. Mining the probiotic genome: Advanced strategies, enhanced benefits, perceived obstacles. Curr Pharm Des 2005; 11: 25-36.
32. Isolauri E, Huurre A, Salminen S, Impivaara O. The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 2004; 34: 1007-10.
33. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease- an extended version. J Pediatr Gastroenterol Nutr 2004; 38: 378-88.
34. Hanifin JM. Atopiform dermatitis: Do we need another confusing name for atopic dermatitis? Br J Dermatol 2002; 147: 430-2.
35. Isolauri E. Dietary modification of atopic disease: Use of probiotics in prevention of atopic dermatitis. Curr Allergy Asthma Reports 2004; 4: 270-5.
36. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159: 1739-45.
37. Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH, et al. Roll of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004; 363: 1689-97.
38. Bashir ME, Louie S, Shi HN, Nagler-Anderson C. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 2004; 172: 6978-87.
39. Rigby RJ, Knight SC, Kamm MA, Stagg AJ. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 2005; 139: 245-56.
40. Hart AL, Lammers K, Brigid P, Vitali B, Rizzello F, Gionchetti P, et al. Modulation of human dendritic cell phenotype and function by probiotics bacteria. Gut 2004; 53: 1602-9.
41. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastro-enterology 1993, 105: 1643-50.
42. Sütas Y, Soppi E, Korhonen H, Syvdoja EL, Saxelin M, Rokka T, et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol 1996; 98: 216-24.
43. Sütas Y, Hurme M, Isolauri E. Dowregulation of antiCD3 antibody-induced IL-4 production by bovine casceins hydrolysed with Lactobacillus GG-derived enzymes. Scand J Immunol 1996; 43: 687-9.
44. Shida K, Takahashi R, Iwadate E, Takamizawa K, Yasui H, Sato T, et al. Lactobacillus casei strain Shirota suppresses serum immuno-globulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002; 32: 563-70.
45. + T cell-mediated skin inflammation. Eur J Immunol 2004; 34: 2520-8.
46. Majamaa H, Isolauri E. Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85.
47. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-10.
48. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaclsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-95.
49. Rosenfeldt V, Benfeldt E, Valerius N, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145: 612-6.
50. Weston S, Halbert AR, Richmond P, Prescott SL. Effect of probiotics on atopic dermatitis: A randomised controlled trial. Arch Dis Child 2005; 90: 892-7.
51. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/ dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 2005; 52:494-500.
52. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease- underscoring the importance of viability. J Pediatr Gastrocnterol Nutr 2003; 36: 223-7.
53. He F, Morita H, Hashimoto H, Hosoda M, Kunisaki J, Ouwehand AC, et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immumol 2002; 109: 1035-6.
54. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised, placebo-controlled trial. Lancet 2001; 357: 1076-79.
55. Kalliomäki M, Salminen S, Poussa. T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease - a 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-71.
56. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119-21.
57. Rinne M, Kalliomäki M, Arvilommi H, Salminen S, Isolauri E. Effect of probictics and breastfeeding on the Bifidobacterium and Lactobacillus/Enterococcus microbiota and humoral immune responses. J Pediatr 2005; 147: 186-91.
58. Pessi T, Sütas Y, Marttinen A, Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: Implications for therapeutic use of probiotics. J Nutr 1998; 128: 2313-8.
59. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. J Am Med Assoc 2001; 286: 944-53.
60. Whelan J. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. J Nutr 1996; 126(Suppl): 1086-91.
61. Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2002; 3: CDO01283.
62. van Gool CJAW, Zeegers MPA, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis - a meta-analysis of placebo- controlled trials. Brit J Dermatol 2004; 150: 728-40.
63. Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999; 5: 900-6.
64. Hoppu U, Kalliomaki M, Isolauri E. Maternal diet rich in saturated fat during breastfeeding is associated with atopic sensitization of the infant. Eur J Clin Nutr 2000; 54: 702-5.
65. Laitinen K, Kalliomaki M, Poussa T, Lagström H, Isolauri E. Evaluation of diet and growth in children with and without atopic eczema: Follow-up study from birth to four years. Brit J Nutr 2005; 94: 565-74.
66. Usami, M, Muraki K, Iwamoto M, Ohata A, Matsushita E, Miki A. Effect of eicosapentaenoic acid (EPA) on tigh junction permeability in intestinal monolayer cells. Clin Nutr 2001; 20: 351-9.
67. Kankaanpol PE, Salminen S, Isolauri E, Lee YK. The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett 2001; 194: 149-53.
68. Gusils C, Cuozzo S, Sesma F, Gonzalez S. Examination of adhesive determinants in three species of Lactobacillus isolated from chicken. Can J Microbiol 2002; 48: 34-42.
69. Kankaanpää, Yang B, Kallio H, Isolauri E, Salminen S. Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surflace properties of lactobacilli. Appl Environ Microbiol 2004; 70: 129-36.
70. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr 2001; 21: 167-92.
71. Thurnham DI, Northrop-Clewes CA, McCullough FS, Das BS, Lunn PG. Innate immunity, gut integrity, and vitamin A in Gambian and Indian infants. J Infect Dis 2000; 182: S23-8.
72. Worm M, Herz U, Krah JM, Renz H, Henz BM. Effects of retinoids on in vitro and in vivo IgE production. Int Arch Allergy Immunology 2001; 124: 233-6.
73. Albers R, Bol M, Bleumink R, Willems AA, Pieters RHH. Effects of supplementation with vitamins A, C, and E, selenium, and zinc on immune function in a murine sensitization model. Nutrition 2003; 19:940-46.
74. Halevy O, Sklan D. Inhibition of arachidonic acid oxidation by ß-carotene, retinol, and alpha-tocopherol. Biochimica et Biophysica Acta 1987; 918: 304-7.
75. Laitinen K, Isolauri E. Management of food allergy: Vitamins, fatty acids or probiotics? Eur J Gastronterol Hepatol 2005; 17: 1305-11.
76. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.
77. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria: Tolerance and safety. Am J Clin Nutr 2004; 79:261-267.
78. Salminen MK, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M, et al. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea, in HIV Patients an antiretroviral therapy: A randomized, placebo-controlled, crossover study. HIV Clin Trials 2004; 5: 183-91.
79. Ouwehand AC, Saxelin M, Salminen S. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis 2004; 39: 1858-60.
80. Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr 2004; 38: 293-7.
81. Gueimonde M, Kalliomäki M, Isolauri E, Salminen S. Probiotic intervention in neonates- will permanent colonization ensue? J Pediatr Gastroenterol Nutr 2006; 42: 604-6.
82. Akarca US. Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs. Curr Pharm Des 2005; 11(14):1779-93.
83. Crittenden R, Bird AR, Gopal P, Henriksson A, Lee YK, Playne MJ. Probiotic research in Australia, New Zealand and the Asia-Pacific region. Curr Pharm Des 2005; 11(1):37-53.
84. Tuohy KM, Rouzaud GC, Bruck WM, Gibson GR. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Curr Pharm Des 2005; 11(1):75-90.